BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33632666)

  • 1. Indication for resection and possibility of observation for intraductal papillary mucinous neoplasm with high-risk stigmata.
    Abe K; Kitago M; Masugi Y; Iwasaki E; Yagi H; Abe Y; Hasegawa Y; Fukuhara S; Hori S; Tanaka M; Nakano Y; Yokose T; Shimane G; Sakamoto M; Kitagawa Y
    Pancreatology; 2021 Jun; 21(4):755-762. PubMed ID: 33632666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term surveillance of branch-duct intraductal papillary mucinous neoplasms without worrisome or high-risk features.
    Lattimore CM; Kane WJ; Subbarao S; Venitti C; Cramer CL; Turkheimer LM; Bauer TW; Turrentine FE; Zaydfudim VM
    J Surg Oncol; 2023 Dec; 128(7):1087-1094. PubMed ID: 37530526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas.
    Ohtsuka T; Fernandez-Del Castillo C; Furukawa T; Hijioka S; Jang JY; Lennon AM; Miyasaka Y; Ohno E; Salvia R; Wolfgang CL; Wood LD
    Pancreatology; 2024 Mar; 24(2):255-270. PubMed ID: 38182527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A resected case of two branch duct-type intraductal papillary mucinous neoplasms showing different clinical courses after a two-year follow-up.
    Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Takimoto M; Tabuchi A; Takano Y; Yamamura E; Nagahama M; Takeyama N; Yokomizo K; Mizukami H; Tanaka JI; Aoki T; Murakami M
    Clin J Gastroenterol; 2017 Jun; 10(3):274-278. PubMed ID: 28258561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT findings and clinical effects of high grade pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms.
    Kim MC; Kim JH; Jeon SK; Kang HJ
    PLoS One; 2024; 19(4):e0298278. PubMed ID: 38683769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
    Tanaka M
    Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the 2012 Fukuoka Consensus Guideline for Intraductal Papillary Mucinous Neoplasm of the Pancreas From a Single Institution Experience.
    Yu S; Takasu N; Watanabe T; Fukumoto T; Okazaki S; Tezuka K; Sugawara S; Hirai I; Kimura W
    Pancreas; 2017 Aug; 46(7):936-942. PubMed ID: 28697135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiological and Pathological Assessment of the 2017 Revised International Association of Pancreatology Consensus Guidelines for Intraductal Papillary Mucinous Neoplasm, With an Emphasis on the Gastric Pyloric Gland Type.
    Nakahodo J; Fukumura Y; Saito T; Mitomi H; Saiura A; Fujisawa T; Ishii S; Isayama H; Kurahayashi I; Yao T
    Pancreas; 2020 Feb; 49(2):216-223. PubMed ID: 32011532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
    Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
    Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
    Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
    Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of efficacy of pancreatic juice cytology for risk classification according to international consensus guidelines in patients with intraductal papillary mucinous neoplasm; a retrospective study.
    Yamakawa K; Masuda A; Nakagawa T; Shiomi H; Toyama H; Takenaka M; Sakai A; Kobayashi T; Tsujimae M; Ashina S; Yamada Y; Tanaka T; Tanaka S; Nakano R; Sato Y; Ikegawa T; Kurosawa M; Fujigaki S; Kutsumi H; Itoh T; Fukumoto T; Kodama Y
    Pancreatology; 2019 Apr; 19(3):424-428. PubMed ID: 30857854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
    Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
    Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
    [No Abstract]   [Full Text] [Related]  

  • 16. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.
    Sahora K; Fernández-del Castillo C; Dong F; Marchegiani G; Thayer SP; Ferrone CR; Sahani DV; Brugge WR; Warshaw AL; Lillemoe KD; Mino-Kenudson M
    Surgery; 2014 Sep; 156(3):611-21. PubMed ID: 25081232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
    Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
    Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of magnetic resonance image for malignant intraductal papillary mucinous neoplasms: the importance of size of enhancing mural nodule within cyst.
    Hong SB; Lee NK; Kim S; Seo HI; Park YM; Noh BG; Kim DU; Han SY; Kim TU
    Jpn J Radiol; 2022 Dec; 40(12):1282-1289. PubMed ID: 35781178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of branch-duct intraductal papillary mucinous neoplasms of the pancreas: state of the art.
    Crippa S; Piccioli A; Salandini MC; Cova C; Aleotti F; Falconi M
    Updates Surg; 2016 Sep; 68(3):265-271. PubMed ID: 27502606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study.
    Johansson K; Mustonen H; Seppänen H; Lehtimäki TE
    BMC Gastroenterol; 2022 Aug; 22(1):394. PubMed ID: 35989322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.